in-vivo modeling of cll and richter's transformation
Published 10 months ago • 138 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
2:19
in vivo modelling of cll into richter’s syndrome
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
1:27
cll patient-derived xenografts recapitulate clonal evolution of richter transformation
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
1:22
advances in our understanding of the factors contributing to richter’s transformation in cll
-
21:38
drawing the line: the rationale behind blood tube collection order
-
7:16
developing a mouse model to elucidate the molecular mechanisms of richter's transformation
-
2:02
loading of the accuject bl injector with the acunex lens
-
1:09
early results from epcore cll-1 trial: subcutaneous epcoritamab in patients with richter’s syndrome
-
1:31
frontline treatment for cll: the changing paradigm
-
1:47
future research priorities and unmet needs in patients with cll
-
2:16
the role of covalent btkis in the management of cll
-
2:05
the role of notch1 mutation in cll
-
1:22
the future of cll treatment and more personalized approaches
-
2:57
murano trial: duvelisib plus venetoclax in r/r cll, sll and richter’s syndrome
-
2:01
transcription factor foxo1 mediates cell survival during bcr inhibitor therapy in cll
-
1:14
cll: ighv mutational status
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
3:01
the predictive value of stereotyped bcr subsets in cll
-
1:52
evaluating surrogacy endpoints in cll clinical trials
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
4:25
cll: state of the art in italy